Dose-response association between cardiovascular health and mortality in cancer survivors

Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 71, 209, 10.3322/caac.21660 Arnold, 2019, Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study, Lancet Oncol, 20, 1493, 10.1016/S1470-2045(19)30456-5 Miller, 2022, Cancer treatment and survivorship statistics, 2022, CA Cancer J Clin, 72, 409, 10.3322/caac.21731 Sarfati, 2016, The impact of comorbidity on cancer and its treatment, CA Cancer J Clin, 66, 337, 10.3322/caac.21342 Spratt, 2021, Treating the patient and not just the cancer: therapeutic burden in prostate cancer, Prostate Cancer Prostatic Dis, 24, 647, 10.1038/s41391-021-00328-1 Jensen, 2017, United States population-based estimates of patient-reported outcomes measurement information system symptom and functional status reference values for individuals with cancer, J Clin Oncol, 35, 1913, 10.1200/JCO.2016.71.4410 Capocaccia, 2015, Life expectancy of colon, breast, and testicular cancer patients: an analysis of US-SEER population-based data, Ann Oncol, 26, 1263, 10.1093/annonc/mdv131 Sturgeon, 2019, A population-based study of cardiovascular disease mortality risk in US cancer patients, Eur Heart J, 40, 3889, 10.1093/eurheartj/ehz766 Florido, 2022, Cardiovascular disease risk among cancer survivors, J Am Coll Cardiol, 80, 22, 10.1016/j.jacc.2022.04.042 Soerjomataram, 2021, Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070, Nat Rev Clin Oncol, 18, 663, 10.1038/s41571-021-00514-z Strongman, 2019, Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases, Lancet North Am Ed, 394, 1041, 10.1016/S0140-6736(19)31674-5 Koene, 2016, Shared risk factors in cardiovascular disease and cancer, Circulation, 133, 1104, 10.1161/CIRCULATIONAHA.115.020406 Zhu, 2023, Racial and ethnic disparities in all-cause and cardiovascular mortality among cancer patients in the U.S, JACC CardioOncol, 5, 55, 10.1016/j.jaccao.2022.10.013 Velusamy, 2023, Screening for coronary artery disease in cancer survivors, JACC: CardioOncol, 5, 22 Rim, 2016, The impact of chronic conditions on the economic burden of cancer survivorship: a systematic review, Expert Rev Pharmacoecon Outcomes Res, 16, 579, 10.1080/14737167.2016.1239533 2018 von Elm, 2008, The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, J Clin Epidemiol, 61, 344, 10.1016/j.jclinepi.2007.11.008 Lloyd-Jones, 2022, Status of cardiovascular health in US adults and children using the American Heart Association's New “Life's Essential 8” Metrics: prevalence estimates from the National Health and Nutrition Examination Survey (NHANES), 2013 through 2018, Circulation, 146, 822, 10.1161/CIRCULATIONAHA.122.060911 dos Santos, 2022, Association of the “weekend warrior” and other leisure-time physical activity patterns with all-cause and cause-specific mortality: a nationwide cohort study, JAMA Intern Med, 182, 840, 10.1001/jamainternmed.2022.2488 Lloyd-Jones, 2022, Life's Essential 8: updating and enhancing the American Heart Association's Construct of Cardiovascular Health: a presidential advisory from the American Heart Association, Circulation, 146, e18, 10.1161/CIR.0000000000001078 Statistics, 2017 Xu, 2016, Deaths: final data for 2013, Natl Vital Stat Rep, 64, 1 Newson, 2013, Attributable and unattributable risks and fractions and other scenario comparisons, Stata J, 13, 672, 10.1177/1536867X1301300402 Isiozor, 2023, Life's Essential 8 and the risk of cardiovascular disease death and all-cause mortality in Finnish men, Eur J Prev Cardiol, 30, 658, 10.1093/eurjpc/zwad040 Yi, 2023, Association of Life's Essential 8 with all-cause and cardiovascular mortality among US adults: a prospective cohort study from the NHANES 2005–2014, Nutr Metab Cardiovasc Dis, 33, 1134, 10.1016/j.numecd.2023.01.021 Lloyd-Jones, 2010, Defining and setting national goals for cardiovascular health promotion and disease reduction, Circulation, 121, 586, 10.1161/CIRCULATIONAHA.109.192703 Rasmussen-Torvik, 2013, Ideal cardiovascular health is inversely associated with incident cancer, Circulation, 127, 1270, 10.1161/CIRCULATIONAHA.112.001183 Herrmann, 2020, Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia, Nat Rev Cardiol, 17, 474, 10.1038/s41569-020-0348-1 Merriel, 2021, Exploring the causes of death among patients with metastatic prostate cancer—a changing landscape, JAMA Netw, 4 Lee, 2023, Smoking habit change after cancer diagnosis: effect on cardiovascular risk, Eur Heart J, ehad199, 10.1093/eurheartj/ehad199 Cespedes Feliciano, 2019, Adipose tissue distribution and cardiovascular disease risk among breast cancer survivors, J Clin Oncol, 37, 2528, 10.1200/JCO.19.00286 Friedenreich, 2020, Physical activity and mortality in cancer survivors: a systematic review and meta-analysis, JNCI Cancer Spectr, 4, pkz080, 10.1093/jncics/pkz080 Lan, 2023, Adherence to healthy diet and risk of cardiovascular disease in adult survivors of childhood cancer in the St. Jude Lifetime Cohort: a cross-sectional study, BMC medicine, 21, 242, 10.1186/s12916-023-02956-x Trudel-Fitzgerald, 2017, Sleep and survival among women with breast cancer: 30 years of follow-up within the Nurses' Health Study, Br J Cancer, 116, 1239, 10.1038/bjc.2017.85 Oh, 2023, Increased risk of cardiovascular disease associated with diabetes among adult cancer survivors: a population-based matched cohort study, Eur J Prev Cardiol, 30, 670, 10.1093/eurjpc/zwad046 Cohen, 2019, Hypertension in cancer patients and survivors, JACC: CardioOncol, 1, 238 Foraker, 2021, Addressing cancer survivors' cardiovascular health using the automated heart health assessment (AH-HA) EHR tool: initial protocol and modifications to address COVID-19 challenges, Contemp Clin Trials Commun, 22, 10.1016/j.conctc.2021.100808